Carrie Clark, Director of Genspect UK, joins Stella O'Malley and Mia Hughes to expose the alarming details of the NHS’s proposed Pathways study on puberty blockers. Despite the Cass Review uncovering major failings at the now-closed Tavistock clinic, the NHS is pushing forward with a new trial that risks repeating the same devastating mistakes on a massive scale.Clark reveals how this £10 million study ignores evidence of harm, fails to include detransitioners, and manipulates scientific data to justify medicalizing vulnerable children. The conversation explores the flawed Dutch Protocol, the suppressed Early Intervention Study, and the NHS’s refusal to follow up on the 9,000 children who passed through GIDS.